IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA
300MG/25MG TBL FLM 56X1
| SÚKL code | 0028657 |
|---|---|
| Name of the product | IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA |
| Supplement | 300MG/25MG TBL FLM 56X1 |
| Strenght | 300MG/25MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 56X1 |
| Route | Oral use |
| Wrap type | |
| Legal status | na lékařský předpis |
| Active substance |
HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDUM) IRBESARTAN (IRBESARTANUM) |
| ATC group | C09DA04 |
| ATC group name | IRBESARTAN A DIURETIKA |
| Doping | Diuretika a maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz www.antidoping.cz/cs/zakazane-leky |
Marketing authorisation information
| Registration Number | EU/1/06/377/026 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Zentiva, k.s., Praha |
| MA Holder country | ČESKÁ REPUBLIKA |
cz